CytomX Therapeutics, Inc. (CTMX)
3.555
+0.06
(+1.57%)
USD |
NASDAQ |
May 19, 13:22
CytomX Therapeutics Research and Development Expense (Quarterly) : 19.02M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Rigel Pharmaceuticals, Inc. | 11.68M |
| Ovid Therapeutics, Inc. | 11.15M |
| Gossamer Bio, Inc. | 43.07M |
| Mirum Pharmaceuticals, Inc. | 97.84M |